Tag: Symvess
Humacyte announces US FDA authorisation extending Symvess shelf life to 36...
Humacyte recently announced that the US Food and Drug Administration (FDA) has authorised an extension of the expiration dating period for Symvess (acellular tissue...
Humacyte’s Symvess supports high rates of limb salvage at 36 months...
Humacyte recently announced the presentation of 36-month data assessing the durability of its Symvess acellular tissue-engineered vessel in extremity arterial trauma patients. The results...
